Dr. Kai Prager

Representative (Senior Scientific/Business Role inferred)

Therapeutic Areas

Drug	Indication	Phase
Urine Portfolio (respons®UDS100)	Urinalysis	Launched
LDL-c direct FS	Cardiovascular Risk Assessment	Launched
Procalcitonin FS	Sepsis/Bacterial Infection	Launched
One step HbA1c analyzer	Diabetes Monitoring	Launched